{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:05:14Z","timestamp":1792695914015,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,12,14]],"date-time":"2019-12-14T00:00:00Z","timestamp":1576281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,12,14]],"date-time":"2019-12-14T00:00:00Z","timestamp":1576281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001833","name":"VU University Amsterdam","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001833","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00198-019-05226-w","type":"journal-article","created":{"date-parts":[[2019,12,14]],"date-time":"2019-12-14T15:02:46Z","timestamp":1576335766000},"page":"251-257","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":98,"title":["Fracture prevention by screening for high fracture risk: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"31","author":[{"given":"T.","family":"Merlijn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.M.A.","family":"Swart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.E.","family":"van der Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"Netelenbos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.J.M.","family":"Elders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,14]]},"reference":[{"key":"5226_CR1","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.jval.2017.02.006","volume":"20","author":"T Dunnewind","year":"2017","unstructured":"Dunnewind T, Dvortsin EP, Smeets HM, Konijn RM, Bos JHJ, de Boer PT, van den Bergh JP, Postma MJ (2017) Economic consequences and potentially preventable costs related to osteoporosis in the Netherlands. Value Health 20:762\u2013768","journal-title":"Value Health"},{"key":"5226_CR2","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s11657-013-0136-1","volume":"8","author":"E Hernlund","year":"2013","unstructured":"Hernlund E, Svedbom A, Ivergard M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Kanis JA (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8:136","journal-title":"Arch Osteoporos"},{"key":"5226_CR3","doi-asserted-by":"crossref","unstructured":"Wells G, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, Coyle D, Tugwell P (2008) Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev CD004523","DOI":"10.1002\/14651858.CD004523.pub3"},{"key":"5226_CR4","doi-asserted-by":"crossref","unstructured":"Wells GA, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, Coyle D, Tugwell P (2008) Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev CD001155","DOI":"10.1002\/14651858.CD001155.pub2"},{"key":"5226_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","volume":"30","author":"JA Kanis","year":"2019","unstructured":"Kanis JA, Cooper C, Rizzoli R, Reginster JY (2019) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 30:3\u201344","journal-title":"Osteoporos Int"},{"key":"5226_CR6","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1503\/cmaj.100771","volume":"182","author":"A Papaioannou","year":"2010","unstructured":"Papaioannou A, Morin S, Cheung AM et al (2010) 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. Can Med Assoc J 182:1864\u20131873","journal-title":"Can Med Assoc J"},{"key":"5226_CR7","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1001\/jama.2018.7498","volume":"319","author":"SJ Curry","year":"2018","unstructured":"Curry SJ, Krist AH, Owens DK et al (2018) Screening for osteoporosis to prevent fractures: us preventive services task force recommendation statement. Jama 319:2521\u20132531","journal-title":"Jama"},{"key":"5226_CR8","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s12445-012-0132-5","volume":"55","author":"PJM Elders","year":"2012","unstructured":"Elders PJM, Dinant GJ, van Geel T, Maartens LWF, Merlijn T, Geijer RMM, Geraets JJXR (2012) NHG-Standaard Fractuurpreventie (tweede herziening). Huisarts Wet 55:452\u2013458","journal-title":"Huisarts Wet"},{"key":"5226_CR9","volume-title":"Screening for osteoporosis in postmenopausal women: a report for the UK National Screening Committee","author":"L Peto","year":"2013","unstructured":"Peto L, Allaby M (2013) Screening for osteoporosis in postmenopausal women: a report for the UK National Screening Committee. Solution for public health, Oxford"},{"key":"5226_CR10","doi-asserted-by":"crossref","unstructured":"Merlijn T, Swart KMA, Van Schoor NM, et al. (2019) The effect of a screening and treatment program for the prevention of fractures in older women: a randomized pragmatic trial. J Bone Min Res Accepted","DOI":"10.1002\/jbmr.3815"},{"key":"5226_CR11","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00198-017-4326-3","volume":"29","author":"KH Rubin","year":"2018","unstructured":"Rubin KH, Rothmann MJ, Holmberg T et al (2018) Effectiveness of a two-step population-based osteoporosis screening program using FRAX: the randomized Risk-stratified Osteoporosis Strategy Evaluation (ROSE) study. Osteoporos Int 29:567\u2013578","journal-title":"Osteoporos Int"},{"key":"5226_CR12","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0140-6736(17)32640-5","volume":"391","author":"L Shepstone","year":"2018","unstructured":"Shepstone L, Lenaghan E, Cooper C et al (2018) Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial. Lancet 391:741\u2013747","journal-title":"Lancet"},{"key":"5226_CR13","unstructured":"Higgins J, Green S (2015) Cochrane handbook for systematic reviews of interventions. The Cochrane Collaboration"},{"key":"5226_CR14","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1046\/j.1532-5415.2002.50257.x","volume":"50","author":"DS Buist","year":"2002","unstructured":"Buist DS, LaCroix AZ, Manfredonia D, Abbott T (2002) Identifying postmenopausal women at high risk of fracture in populations: a comparison of three strategies. J Am Geriatr Soc 50:1031\u20131038","journal-title":"J Am Geriatr Soc"},{"key":"5226_CR15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/00005650-200503000-00012","volume":"43","author":"AZ Lacroix","year":"2005","unstructured":"Lacroix AZ, Buist DS, Brenneman SK, Abbott TA 3rd (2005) Evaluation of three population-based strategies for fracture prevention: results of the osteoporosis population-based risk assessment (OPRA) trial. Med Care 43:293\u2013302","journal-title":"Med Care"},{"key":"5226_CR16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00223-004-0101-5","volume":"76","author":"RJ Barr","year":"2005","unstructured":"Barr RJ, Stewart A, Torgerson DJ, Seymour DG, Reid DM (2005) Screening elderly women for risk of future fractures--participation rates and impact on incidence of falls and fractures. Calcif Tissue Int 76:243\u2013248","journal-title":"Calcif Tissue Int"},{"key":"5226_CR17","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/jbmr.1478","volume":"27","author":"EM Clark","year":"2012","unstructured":"Clark EM, Gould V, Morrison L, Ades AE, Dieppe P, Tobias JH (2012) Randomized controlled trial of a primary care-based screening program to identify older women with prevalent osteoporotic vertebral fractures: Cohort for Skeletal Health in Bristol and Avon (COSHIBA). J Bone Miner Res 27:664\u2013671","journal-title":"J Bone Miner Res"},{"key":"5226_CR18","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00198-009-1007-x","volume":"21","author":"RJ Barr","year":"2010","unstructured":"Barr RJ, Stewart A, Torgerson DJ, Reid DM (2010) Population screening for osteoporosis risk: a randomised control trial of medication use and fracture risk. Osteoporos Int 21:561\u2013568","journal-title":"Osteoporos Int"},{"key":"5226_CR19","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.cct.2010.03.012","volume":"31","author":"DL Schneider","year":"2010","unstructured":"Schneider DL, Worley K, Beard MK, Iannini M, Ko M, McCallum J, Pulicharam R, Steinbuch M (2010) The primary care osteoporosis risk of fracture screening (POROS) study: design and baseline characteristics. Contemp Clin Trials 31:336\u2013344","journal-title":"Contemp Clin Trials"},{"key":"5226_CR20","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/joim.12586","volume":"281","author":"M Katsoulis","year":"2017","unstructured":"Katsoulis M, Benetou V, Karapetyan T, Feskanich D, Grodstein F, Pettersson-Kymmer U, Eriksson S, Wilsgaard T, J\u00f8rgensen L, Ahmed LA, Sch\u00f6ttker B, Brenner H, Bellavia A, Wolk A, Kubinova R, Stegeman B, Bobak M, Boffetta P, Trichopoulou A (2017) Excess mortality after hip fracture in elderly persons from Europe and the USA: the CHANCES project. J Intern Med 281:300\u2013310","journal-title":"J Intern Med"},{"key":"5226_CR21","doi-asserted-by":"publisher","first-page":"244","DOI":"10.7326\/M15-0969","volume":"164","author":"HD Nelson","year":"2016","unstructured":"Nelson HD, Fu R, Cantor A, Pappas M, Daeges M, Humphrey L (2016) Effectiveness of breast cancer screening: systematic review and meta-analysis to update the 2009 US PREVENTIVE SERVICES TASK FORCE RECOMMENDATION. Ann Intern Med 164:244\u2013255","journal-title":"Ann Intern Med"},{"key":"5226_CR22","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.clcc.2016.03.003","volume":"15","author":"D Fitzpatrick-Lewis","year":"2016","unstructured":"Fitzpatrick-Lewis D, Ali MU, Warren R, Kenny M, Sherifali D, Raina P (2016) Screening for Colorectal Cancer: A Systematic Review and Meta-Analysis. Clin Colorectal Cancer 15:298\u2013313","journal-title":"Clin Colorectal Cancer"},{"key":"5226_CR23","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S0140-6736(18)31379-5","volume":"392","author":"KMA Swart","year":"2018","unstructured":"Swart KMA, Merlijn T, Netelenbos JC, Elders PJM (2018) A closer look at SCOOP: screening for fracture prevention. Lancet 392:552","journal-title":"Lancet"},{"key":"5226_CR24","doi-asserted-by":"crossref","unstructured":"Reid IR, Horne AM, Mihov B, Stewart A, Garratt E, Wiessing KR, Bolland MJ, Bastin S, Gamble GD (2019) Anti-fracture efficacy of zoledronate in subgroups of osteopenic postmenopausal women: secondary analysis of a randomized controlled trial. J Intern Med","DOI":"10.1111\/joim.12901"},{"key":"5226_CR25","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa1808082","volume":"379","author":"IR Reid","year":"2018","unstructured":"Reid IR, Horne AM, Mihov B, Stewart A, Garratt E, Wong S, Wiessing KR, Bolland MJ, Bastin S, Gamble GD (2018) Fracture prevention with zoledronate in older women with osteopenia. N Engl J Med 379:2407\u20132416","journal-title":"N Engl J Med"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-019-05226-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-019-05226-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-019-05226-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,12]],"date-time":"2020-12-12T19:24:00Z","timestamp":1607801040000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-019-05226-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,14]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["5226"],"URL":"https:\/\/doi.org\/10.1007\/s00198-019-05226-w","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,14]]},"assertion":[{"value":"26 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The manuscript does not contain patient data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and informed consent"}}]}}